Acta Ophthalmol

1. SKJOTH JB, Nielsen H, Orskov M, Cehofski L, et al
   Diabetic retinopathy in Greenland and Denmark-Can differences in risk factors explain the lower prevalence in Greenland?
   Acta Ophthalmol. 2026 Jan 28. doi: 10.1111/aos.70064.
   

   >> Share

   
   

   
   Am Heart J

2. CHANG LS, Hassan S, Chasse J, Stern G, et al
   Safety of a remote disease management program to improve sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prescribing in type 2 diabetes with elevated cardiovascular or kidney risk.
   Am Heart J. 2026 Jan 27:107359. doi: 10.1016/j.ahj.2026.107359.
   

   >> Share

   
   

   
   Am J Clin Nutr

3. PETERSEN EE, Hansen JK, Torp N, Gram-Kampmann E, et al
   Health-related quality of life, compliance and sustained adherence on a Low-Carbohydrate High-Fat diet compared with a High-Carbohydrate Low-Fat diet in people with type 2 diabetes.
   Am J Clin Nutr. 2026 Jan 27:101211. doi: 10.1016/j.ajcnut.2026.101211.
   

   >> Share

   
   

   
   Angiology

4. DU X, Liu R, Guo D, Qiu Z, et al
   Predictive Value of Nutritional Scores for Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus.
   Angiology. 2026 Jan 29:33197251399868. doi: 10.1177/00033197251399868.
   

   >> Share

   
   

   
   BMC Ophthalmol

5. HARLEY O, Amelia YS, Gustianty E, Soetedjo NNM, et al
   Resveratrol as a multitarget modulator in diabetic retinopathy: a systematic review of in vitro and in vivo studies.
   BMC Ophthalmol. 2026;26:55.
   

   >> Share

   
   
6. KHATHAMI AA, Baklola M, Alalyani MA, Aljuaid AT, et al
   Multimodal artificial intelligence in retinal vascular and neovascular macular diseases: a systematic review of diagnostic and prognostic applications.
   BMC Ophthalmol. 2025 Dec 24. doi: 10.1186/s12886-025-04561.
   

   >> Share

   
   

   
   BMC Pediatr

7. ILKHANIPOOR H, Taghadosi Far N, Moravej H, Barzegar H, et al
   Dyslipidemia in children with type 1 diabetes across age groups in Southern Iran: is it time to rethink guidelines?
   BMC Pediatr. 2026 Jan 26. doi: 10.1186/s12887-025-06504.
   

   >> Share

   
   

   
   Circulation

8. XU J, Wu Y, Song P, Zhang M, et al
   Retraction of: Proteasome-Dependent Degradation of Guanosine 5'-Triphosphate Cyclohydrolase I Causes Tetrahydrobiopterin Deficiency in Diabetes Mellitus.
   Circulation. 2026 Jan 30. doi: 10.1161/CIR.0000000000001420.
   

   >> Share

   
   

   
   Diabet Med

9. CHI K, Liang Y, Li Y, Luo Z, et al
   Higher dietary magnesium intake and lower risks of all-cause, cardiovascular and kidney disease mortality in diabetes participants: A large cross-population cohort study.
   Diabet Med. 2026 Jan 23:e70223. doi: 10.1111/dme.70223.
   

   >> Share

   
   
10. BUDIANTO IR, Gosal E, Djuartina T, Sutrisno A, et al
    The association between Apolipoprotein A1, Apolipoprotein B and their ratio with diabetes-related neuropathy in elderly patients.
    Diabet Med. 2026 Jan 23:e70227. doi: 10.1111/dme.70227.
    

    >> Share

    
    
11. MECANI R, Muka T, Cigler M, Basta S, et al
    The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerations.
    Diabet Med. 2026 Jan 23:e70220. doi: 10.1111/dme.70220.
    

    >> Share

    
    
12. MCCARTHY A, Thomas J, Avila E, Koutroukas V, et al
    Associations between impaired awareness of hypoglycaemia and mental health in insulin-treated type 2 and type 1 diabetes in the Hypo-METRICS study.
    Diabet Med. 2026 Jan 23:e70194. doi: 10.1111/dme.70194.
    

    >> Share

    
    
13. CARRIERI F, Scott EM, Murphy HR
    Invited commentary: Advancing the management of type 2 diabetes in pregnancy.
    Diabet Med. 2026 Jan 26:e70219. doi: 10.1111/dme.70219.
    

    >> Share

    
    
14. KUNDU M, Funnell MP, Karimi Z, Kunutsor SK, et al
    Prognostic models for all-cause and cardiovascular mortality in type 2 diabetes: Systematic review.
    Diabet Med. 2026 Jan 28:e70218. doi: 10.1111/dme.70218.
    

    >> Share

    
    

    
    Diabetes

15. XIE C, White JB, Huang W, Horowitz M, et al
    Endogenous Glucagon-Like Peptide 1 Enhanced by Vildagliptin Reduces Triglyceride Appearance During Intraduodenal Fat Infusion in Type 2 Diabetes.
    Diabetes. 2026 Jan 27:db250980. doi: 10.2337/db25-0980.
    

    >> Share

    
    

    
    Diabetes Care

16. TEUFEL F, Orgutsova K, Genitsaridi I, Carrillo-Larco RM, et al
    Global, Regional, and National Estimates of Undiagnosed Diabetes in Adults: Findings From the 2025 IDF Diabetes Atlas.
    Diabetes Care. 2026 Jan 28:dc252583. doi: 10.2337/dc25-2583.
    

    >> Share

    
    
17. BAKHSH A, Saleemi A, Budhram D, Zhang Y, et al
    Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 Diabetes.
    Diabetes Care. 2026 Jan 27:dc251955. doi: 10.2337/dc25-1955.
    

    >> Share

    
    
18. LI HY, Chan TK, Co Shih K, Cheung BMY, et al
    GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials.
    Diabetes Care. 2026 Jan 26:dc251929. doi: 10.2337/dc25-1929.
    

    >> Share

    
    
19. GISINGER T, He JH, Oyeka CP, Ma J, et al
    Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the LookAHEAD Trial.
    Diabetes Care. 2026 Jan 26:dc252465. doi: 10.2337/dc25-2465.
    

    >> Share

    
    

    
    Diabetes Obes Metab

20. NARDONE M, Moedt E, Heerspink HJL, Davies MJ, et al
    Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trial.
    Diabetes Obes Metab. 2026 Jan 27. doi: 10.1111/dom.70520.
    

    >> Share

    
    
21. ZHU X, Lipscombe LL, Shulman R, Lovblom LE, et al
    Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, Canada.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70514.
    

    >> Share

    
    
22. GAO FM, Kishore K, Pandey D, Jahanabadi H, et al
    Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data.
    Diabetes Obes Metab. 2026 Jan 29. doi: 10.1111/dom.70509.
    

    >> Share

    
    
23. LEI L, Li Y, Chen S, Zou Y, et al
    Peptidylarginine deiminase 4-mediated neutrophil extracellular trap formation aggravates beta-cell damage in type 1 diabetes: A multi-model study.
    Diabetes Obes Metab. 2026 Jan 29. doi: 10.1111/dom.70442.
    

    >> Share

    
    
24. KEELS JN, LaPlante RD, Lee CS, Dwyer AA, et al
    Prevalence of new-onset diabetes following COVID-19 infection: A systematic review and meta-analysis.
    Diabetes Obes Metab. 2026 Jan 28. doi: 10.1111/dom.70508.
    

    >> Share

    
    
25. ABDEL-RAHMAN SM, Al-Shiab R, Shah E, Guldan M, et al
    Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.
    Diabetes Obes Metab. 2026 Jan 28. doi: 10.1111/dom.70506.
    

    >> Share

    
    
26. PAVLOU P, Anandhakrishnan A, Athanasiadou KI, Brackenridge A, et al
    Discordant real-world glycaemic outcomes with Omnipod 5 and MiniMed 780G in adults with type 1 diabetes: Why validated measures matter.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70480.
    

    >> Share

    
    
27. DICEMBRINI I, Poggi CD, Del Vescovo GG, Marinelli C, et al
    Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal-bolus insulin therapy: A randomised controlled trial.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70511.
    

    >> Share

    
    
28. 
    Correction to 'Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta-analysis of randomised controlled trials'.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70518.
    

    >> Share

    
    
29. GU Z, Chen L, Zhan K, Xi X, et al
    Development of the health economic model for type 2 diabetes considering glycaemic variability.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70451.
    

    >> Share

    
    
30. SUN M, Wang X, Lu Z, Yang Y, et al
    GLP-1RAs versus metformin and Parkinson's risk in type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70459.
    

    >> Share

    
    
31. MORRISSEY PI, Clarke ED, Loh XT, Collins CE, et al
    Nutrition interventions for anxiety, depression, stress and/or diabetes-related distress in individuals with diabetes: A systematic review and meta-analysis of randomised controlled trials.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70444.
    

    >> Share

    
    
32. MAKINO H, Kasahara M, Takashima R, Kasama S, et al
    Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double-blind, placebo-controlled trial.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70485.
    

    >> Share

    
    
33. LI N, Sun J, Li H, Li C, et al
    Drug-gene interactions and the risk of diabetic microvascular complications: A population-based cohort study.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70501.
    

    >> Share

    
    
34. BORLONGAN LAZ, Samante FLD, Ontingco AJM, Tilbe JPA, et al
    Impact of luseogliflozin on metabolic health, lipid profiles, and cardiovascular outcomes in patients with type II diabetes: A systematic review and network meta-analysis.
    Diabetes Obes Metab. 2026 Jan 25. doi: 10.1111/dom.70482.
    

    >> Share

    
    

    
    Diabetologia

35. GITELMAN SE, Simmons K, Sherr JL, Quattrin T, et al
    Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. R
    Diabetologia. 2026 Jan 24. doi: 10.1007/s00125-026-06673.
    

    >> Share

    
    
36. SHARPE H, Lam GY
    The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review.
    Diabetologia. 2026 Jan 26. doi: 10.1007/s00125-025-06653.
    

    >> Share

    
    
37. BENTZEN JMM, Brask-Thomsen PK, Krogsbaek M, Hu X, et al
    Dermal fibroblast mitochondrial profiles in painful diabetic neuropathy.
    Diabetologia. 2026 Jan 26. doi: 10.1007/s00125-025-06660.
    

    >> Share

    
    
38. GIUDICELLI G, Krause N, Turin-Huet V, Robert M, et al
    Type 2 diabetes remission and metabolic outcomes 5 years after Roux-en-Y gastric bypass in young vs older adults: a multicentre matched cohort study.
    Diabetologia. 2026 Jan 29. doi: 10.1007/s00125-025-06665.
    

    >> Share

    
    
39. SIMO R, Hernandez C, Frontoni S, Sbraccia P, et al
    Relationship between retinal neurodysfunction and cognitive impairment in type 2 diabetes: results of the RECOGNISED cross-sectional study.
    Diabetologia. 2026 Jan 29. doi: 10.1007/s00125-025-06664.
    

    >> Share

    
    

    
    J Am Coll Cardiol

40. VERDECCHIA P, Angeli F, Reboldi G
    The Relation Between Blood Pressure and Outcomes in Diabetes: With or Without the J Curve?
    J Am Coll Cardiol. 2026 Jan 28:S0735-1097(25)10423.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

41. RAMA CHANDRAN S, Koh Shimin J, Liu C, Xin Yu Lee I, et al
    Relationship between continuous glucose monitoring and corneal neuropathy in type 2 diabetes.
    J Clin Endocrinol Metab. 2026 Jan 28:dgag030. doi: 10.1210.
    

    >> Share

    
    

    
    J Diabetes Complications

42. LAN NSR, Fegan PG, Jenkins AJ
    High risk, low evidence: Need for more research on lipid-lowering therapies for people with type 1 diabetes.
    J Diabetes Complications. 2026;40:109268.
    

    >> Share

    
    

    
    J Hypertens

43. WANG K, Kroon AA, de Galan BE, Berendschot TTJM, et al
    Associations of blood pressure with retinal arteriolar narrowing and urinary albumin excretion are modified by prediabetes: the Maastricht study.
    J Hypertens. 2026;44:461-469.
    

    >> Share

    
    
44. GILL E, Jin X, Fernandez C, Urbina EM, et al
    Association of hypertension disorders of pregnancy and left ventricular remodeling after 15 years follow-up: findings from the Bogalusa Heart Study.
    J Hypertens. 2025 Dec 18. doi: 10.1097/HJH.0000000000004216.
    

    >> Share

    
    

    
    Kidney Int

45. PATEL HA, Wang J, Zinn CJ, Learmonth M, et al
    Targeting Cellular Senescence in Diabetic Kidney Disease: Potential of Regenerative, Cell-based Therapies and Other Senotherapeutic Approaches.
    Kidney Int. 2026 Jan 23:S0085-2538(26)00054-2. doi: 10.1016/j.kint.2025.
    

    >> Share

    
    

    
    Metabolism

46. GIUSTINA A, di Filippo L, Aleksova A, Bollerslev J, et al
    Consensus statement on vitamin D role in metabolic health.
    Metabolism. 2026;176:156484.
    

    >> Share

    
    
47. LIN Z, Lv D, Zha H, Liu H, et al
    HMGCS2 desuccinylation modulates acetoacetate to drive tubule-macrophage inflammatory crosstalk in diabetic kidney disease.
    Metabolism. 2026;177:156510.
    

    >> Share

    
    

    
    Pediatr Diabetes

48. COHEN M, Weiss L, Weiss R, Shehadeh N, et al
    Apelin and Myostatin Levels in Adolescents With Type-1-Diabetes.
    Pediatr Diabetes. 2025;2025:1578938.
    

    >> Share

    
    

    
    PLoS One

49. JAYANTI RP, Cho YS, Soedarsono S, Kim HJ, et al
    Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure.
    PLoS One. 2026;21:e0340133.
    

    >> Share

    
    
50. LI Z, Chen X, Hu W, Li G, et al
    The relationship between METS-IR and the risk of diabetes incidence in rural adults in China: A retrospective cohort study based on dynamic population.
    PLoS One. 2026;21:e0341612.
    

    >> Share

    
    
51. DATTANI R, Ul-Haq Z, Shah M, Goldet G, et al
    Correction: Association and progression of multi-morbidity with Chronic Kidney Disease stage 3a secondary to Type 2 Diabetes Mellitus, grouped by albuminuria status in the multi-ethnic population of Northwest London: A real-world study.
    PLoS One. 2026;21:e0341903.
    

    >> Share

    
    
52. JARAB AS, Al-Qerem WA, Alqudah S, Alzoubi KH, et al
    Correction: Insulin-self administration among individuals with diabetes: Implications for improved practices.
    PLoS One. 2026;21:e0341749.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

53. SHIVANI ST, LeMasters BE, Ravula T, Esterly HJ, et al
    A structural model of toxic amyloid oligomers involved in type 2 diabetes.
    Proc Natl Acad Sci U S A. 2026;123:e2528103123.
    

    >> Share

    
    
54. LEMASTERS BE, Fields CR, Lomont JP, Chalyavi F, et al
    Mammals that can develop type 2 diabetes have a similarly structured beta-sheet amyloid oligomer.
    Proc Natl Acad Sci U S A. 2026;123:e2530570123.
    

    >> Share

    
    
55. WU S
    A neuron-astrocyte signaling axis in the ACC sustains diabetic neuropathic pain.
    Proc Natl Acad Sci U S A. 2026;123:e2533902123.
    

    >> Share

    
    

    
    Stroke Vasc Interv Neurol

56. PERNG PS, Chang Y, Chuang MT, Wong CE, et al
    GLP-1 Receptor Agonists and Clinical Outcomes after Endovascular Treatment of Unruptured Aneurysms in Type 2 Diabetes.
    Stroke Vasc Interv Neurol. 2025;5:e001933.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share